Calumet (NASDAQ:CLMT) Price Target Raised to $60.00

Calumet (NASDAQ:CLMT) had its price objective upped by HC Wainwright from $33.00 to $60.00 in a research report released on Monday,Benzinga reports. HC Wainwright currently has a buy rating on the oil and gas company’s stock. HC Wainwright also issued estimates for Calumet’s Q1 2026 earnings at ($0.61) EPS, Q2 2026 earnings at ($0.59) EPS, Q3 2026 earnings at ($0.26) EPS, Q4 2026 earnings at ($0.30) EPS, FY2026 earnings at ($1.76) EPS and FY2027 earnings at $1.07 EPS.

Other analysts also recently issued research reports about the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Calumet in a research note on Monday, December 29th. Wall Street Zen cut Calumet from a “buy” rating to a “hold” rating in a research note on Sunday, December 14th. UBS Group reaffirmed a “neutral” rating and set a $26.00 price target on shares of Calumet in a research report on Friday, February 13th. TD Cowen lifted their price objective on Calumet from $19.00 to $25.00 and gave the company a “hold” rating in a report on Thursday, March 5th. Finally, The Goldman Sachs Group boosted their price objective on Calumet from $24.00 to $34.00 and gave the company a “buy” rating in a research report on Thursday, March 12th. Four research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $30.17.

Calumet Stock Performance

Shares of NASDAQ:CLMT opened at $34.59 on Monday. The company has a 50 day moving average price of $27.64 and a two-hundred day moving average price of $22.21. The company has a market capitalization of $3.00 billion, a PE ratio of -88.69 and a beta of 0.85. Calumet has a 52 week low of $7.68 and a 52 week high of $36.94.

Calumet (NASDAQ:CLMT) last announced its quarterly earnings results on Friday, February 27th. The oil and gas company reported ($0.43) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.67) by $0.24. The firm had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $1.04 billion. During the same period in the prior year, the business earned ($0.47) earnings per share. The company’s revenue for the quarter was up 9.4% compared to the same quarter last year. On average, sell-side analysts forecast that Calumet will post -3.02 earnings per share for the current year.

Hedge Funds Weigh In On Calumet

Large investors have recently added to or reduced their stakes in the company. Covestor Ltd raised its stake in shares of Calumet by 29.1% in the 4th quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock valued at $43,000 after purchasing an additional 492 shares during the period. O Keefe Stevens Advisory Inc. boosted its position in shares of Calumet by 2.2% during the third quarter. O Keefe Stevens Advisory Inc. now owns 27,416 shares of the oil and gas company’s stock worth $500,000 after buying an additional 599 shares during the period. ProShare Advisors LLC grew its holdings in shares of Calumet by 6.9% during the fourth quarter. ProShare Advisors LLC now owns 12,613 shares of the oil and gas company’s stock worth $251,000 after buying an additional 817 shares in the last quarter. Aster Capital Management DIFC Ltd grew its holdings in shares of Calumet by 294.7% during the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock worth $33,000 after buying an additional 1,229 shares in the last quarter. Finally, Islay Capital Management LLC acquired a new stake in Calumet in the 4th quarter valued at approximately $25,000. Institutional investors own 34.41% of the company’s stock.

Key Headlines Impacting Calumet

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: HC Wainwright raised Q1–Q4 2026 and FY2026 EPS estimates and boosted FY2027 to $1.07, while keeping a Buy rating and $60 target — this is the core bullish catalyst for the recent rally. Calumet (NASDAQ:CLMT) Stock Price Expected to Rise, HC Wainwright Analyst Says
• Positive Sentiment: Analyst-driven optimism produced a volume‑backed move (Zacks notes a ~12% intraday surge), suggesting momentum and renewed investor interest after the estimate upgrades. Calumet, Inc. (CLMT) Soars 12%: Is Further Upside Left in the Stock?
• Neutral Sentiment: Coverage and commentary are prompting re‑rating conversations; Yahoo Finance looks at valuation after the recent run, which could temper enthusiasm if multiples appear stretched versus fundamentals. A Look At Calumet (CLMT) Valuation After Its Recent Share Price Surge
• Negative Sentiment: Despite upgrades, consensus full‑year estimates remain negative (noted around ($3.02) previously) and the company has a history of volatile quarterly results — fundamentals still need to improve to justify a $60 target, leaving downside risk if momentum fades. MarketBeat CLMT Overview

About Calumet

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.